naturemary plans Calgary manufacturing and innovation hub for pain relief R&D
naturemary will open a million-dollar manufacturing and innovation hub in Calgary this fall, expanding its research, formulation, testing and production work. The move signals a bigger push beyond consumer products as the company builds technologies aimed at future pain-management solutions.
Why it matters: - naturemary is adding Canadian research and production capacity at a time when the Calgary company is moving beyond plant-based consumer products into broader pain innovation. - The new hub could speed development of new formulations, delivery systems and technologies aimed at future pain-management options. - The expansion also supports naturemary’s push to build more Canadian intellectual property and manufacturing capability.
What happened: - naturemary announced the upcoming launch of a new manufacturing and innovation hub in Calgary, Alberta. - The facility is a million-dollar laboratory and production site. - Operations are scheduled to begin this fall, with an official launch expected in October 2026. - Founder and CEO Sonia Kalra and Co-Founder and President Kapil Kalra are leading the company’s expansion.
The details: - The Calgary hub will combine product development, formulation, testing, quality processes and manufacturing in one location. - The site will also support ongoing research into naturemary’s proprietary +BioTerpene Technology platform. - naturemary currently sells plant-based topical pain relief products through pharmacy, grocery, specialty and other retail channels. - The company is extending research beyond its current portfolio to study new formulations, delivery systems and technologies for pain management. - naturemary has expanded its Canadian retail presence while also pursuing international opportunities, including in Asia. - The company describes its long-term strategy as building a pathway from accessible consumer health products today to more advanced pain-management solutions in the future.
Between the lines: - The new facility signals a shift from a brand built around retail products to a company aiming to own more of the underlying science and technology. - Sonia Kalra framed the expansion as a bet on the space between pharmaceuticals and natural products, where naturemary sees room for science-driven innovation. - Kapil Kalra said the lab and production space gives the team room to ask bigger questions about pain and build products around those answers.
What's next: - The Calgary hub is expected to come online in October 2026. - naturemary will use the facility to advance research, develop new technologies and support future product pipelines. - The company is likely to keep balancing current retail growth with longer-term investment in intellectual property and advanced pain relief solutions.
The bottom line: - naturemary is using a new Calgary hub to scale from consumer pain products into a broader Canadian pain innovation platform.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
International Manufacturing Update
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.